Back to search

Article

Effect of 5-Azacitine Treatment on Redox Status and Inflammatory Condition in MDS Patients

2021-12-08

Abstract excerpt

This study focused on the impact of the treatment with the hypomethylating agent 5-Azacitidine on the redox status and inflammation in 24 MDS patients. Clinical and genetic features of MDS patients were recorded and peripheral blood samples were used to determine the activity of the endogenous antioxidant defense system (superoxide dismutase, SOD, catalase, CAT, glutathion peroxidase, GPx, and reductase, GRd, acti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8f8da4c0-d0b1-5246-8c34-f33a468addb9
DOI
10.20944/preprints202112.0137.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of 5-Azacitine Treatment on Redox Status and Inflammatory Condition in MDS PatientsDOI 10.20944/preprints202112.0137.v1
Select a neighboring publication to make it the new centre.